Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...
Coro is a highly accurate breastfeeding monitor for new mothers that's debuting at CES 2026. Back in 2002, my third daughter was born 11 weeks premature. Weighing just 1 pound, 1 ounce, she was the ...
VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...
Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for side effects. Now new research by Fox Chase Cancer Center physicians shows ...
Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to ...
Ribosomes don’t just make proteins—they can sense when something’s wrong. When they collide, they send out stress signals that activate a molecule called ZAK. Researchers uncovered how ZAK recognizes ...
On the first day of school this fall, students across New Hampshire experienced a revolutionary change to their education: the dawn of the bell-to-bell cell phone ban. Students predicted the ban would ...
At New Zealand's Kawaiicon cybersecurity convention, organizers hacked together a way for attendees to track CO 2 levels throughout the venue—even before they arrived. Hacker conferences—like all ...
Please provide your email address to receive an email when new articles are posted on . CAR T-cell therapy for cancer may be associated with new-onset autoimmune disease. Autoimmune events in after ...
The semiconductor industry is increasingly turning to artificial intelligence as the solution for increasing complexity in test analytics, hoping algorithms can tame the growing flood of production ...
President Donald Trump has called for the United States to test its nuclear weapons for the first time in three decades. But Trump’s statements about testing — in particular, whether other nations are ...
New Guardant Reveal offering provides oncologists with tissue-free solution to monitor treatment response and detect early disease progression with unprecedented speed and sensitivity Reveal is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback